Researchers from Queen Mary University of London’s Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) at Charité have published findings from the world’s largest study to date on the genetic regulation of blood proteins.

Researchers analyzing data from the National Institutes of Health’s All of Us Research Program have found that a patient’s step count following surgery is a powerful, objective predictor of recovery, outperforming other metrics such as heart rate variability and self-reported wellness.

A blood test predicts the tumor microenvironment that affects treatment response. Researchers at Stanford Medicine and the Mayo Clinic find nine cellular neighborhoods shared among most cancer cases.

Baylor College of Medicine researchers have found that the human brain is capable of sophisticated language processing while in an unconscious state from general anesthesia. The findings, published in the latest edition of Nature, challenge what we know about the role of consciousness and cognition, and could open new ways of understanding memory, language and brain-computer interfaces.

About The Study: The findings of this systematic review and meta-analysis suggest that single and repeated intravenous ketamine infusions are efficacious in reducing suicidal and depressive symptoms in patients with a major depressive episode in the acute phase, while longer-term outcomes are not well established. 

About The Study: In this randomized clinical trial, genotype-guided prescribing of selective serotonin reuptake inhibitors (SSRIs) did not improve control of depression symptoms at 3 months compared with usual care but was associated with higher depression remission rates at 6 months. These findings suggest a possible longer-term clinical benefit and indicate that future studies should focus on the durability and long-term impact of genotype-guided prescribing in the management of depressive symptoms.

Biodiversity loss is directly threatening human health and welfare, according to new research led by the University of Bristol.  The study, published in Nature today [6 May] reveals, for the first time, how the decline of insect pollinators undermines essential ecosystem services that support human nutrition and livelihoods.  Biodiversity also plays a vital role in supporting people’s everyday health and resilience, too.

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain.